Research for accuracy in disease detection and medical intervention in newborn screening system using tandem mass spectrometry

串联质谱新生儿筛查系统疾病检测和医疗干预准确性研究

基本信息

项目摘要

The subjects in newborn screening pilot study using tandem mass spectrometry were investigated in order to establish the practical screening system in Japan.The tentative cutoff values were tested using the dried blood spots of the patients with target disorders in this project, such as multiple acyl-CoA dehydrogenation defect (GA-II), medium-chain acyl-CoA dehydrogenase (MCAD) deficiency, very-long-chain aryl-CoA dehydrogenase deficiency, and multiple carboxylase deficiency. The ratios of propionylcarnitine to acetylcarnitine were shown to be better marker for the screening of propionic academia and calssical methylmalonic aciduria.The severity of the diseases in patients found in this screening were estimated by the measurement of enzyme activities and the analysis of DNA mutation, which were done in cooperation with the researchers in Hiroshima University and Kyoto University. Therapies for the patients were conducted based on the results in this categories, and almost all patients, except for those with the severest form of the disease, are in good condition.The methods were modified using rust-free N2 drier and less expensive reagent to improve the sample quality and cost burden.We have analyzed about 200,000 dried blood spots and found 25 patients, which enable us to estimate the frequency of target diseases in Japan. In Japan, organic acidemias, such as propionic acidemia and glutaric aciduia type I, are relatively common, and fatty acid oxidation disorders, such as MCAD defiency and GA-II, are not so rare as believed before. It is suggested that screening system in Japan, including medical care for the patients, should be modified for such target diseases.
为了在日本建立实用的筛查系统,对使用串联质谱法进行新生儿筛查初步研究的受试者进行了调查。使用该项目中目标疾病患者的干血斑测试了暂定截止值,如多重酰基辅酶A脱氢酶缺陷(GA-II)、中链酰基辅酶A脱氢酶缺陷(MCAD)、极长链芳基辅酶A脱氢酶缺陷、和多种羧化酶缺乏症。丙酰肉毒碱与乙酰肉毒碱的比值是筛选丙酸尿症和甲基丙二酸尿症的较好指标,本研究与广岛大学和京都大学的研究人员合作,通过测定酶活性和分析DNA突变来估计筛选中发现的患者的疾病严重程度。根据这类结果对病人进行治疗,除最严重的病人外,几乎所有病人的情况都很好。我们改进了方法,使用了无锈的N2干燥剂和较便宜的试剂,以提高样品质量和费用负担。我们分析了约20万个干血斑,发现25例病人,这使我们能够估计日本目标疾病的频率。在日本,有机酸血症,如丙酸血症和I型谷氨酸血症,是相对常见的,脂肪酸氧化障碍,如MCAD缺乏症和GA-II,并不像以前认为的那样罕见。建议日本的筛查系统,包括对患者的医疗护理,应针对这些目标疾病进行修改。

项目成果

期刊论文数量(27)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
但馬剛: "高速液体クロマトグラフィ法による有機酸・脂肪酸代謝異常症の酵素診断"日本マススクリーニング学会誌. 13(1). 39-45 (2003)
Tsuyoshi Tajima:“使用高效液相色谱法进行有机酸/脂肪酸代谢紊乱的酶诊断”,日本大众筛查学会杂志 13(1) (2003)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Shigematsu Y: "Newborn mass screening and selective screening using electrospray tandem mass spectrometry in Japan"J Chromatogr B. 776(1). 39-48 (2002)
Shigematsu Y:“日本使用电喷雾串联质谱法进行新生儿大规模筛查和选择性筛查”J Chromatogr B. 776(1)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yorifuji T: "Unexpectedly high prevalence of the mild form of propionic acidemiain Japan : presence of a common mutation and possible clinical implications."Hum Genet. 112(2). 161-165 (2002)
Yorifuji T:“日本轻度丙酸血症的患病率出人意料地高:存在常见突变和可能的临床影响。”Hum Genet。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Fukao T, Zhang GX, Sakura N, Kubo T, Yamaga H, Hazama A, Kohno Y, Matsuo N, Kondo M, Yamaguchi S, Shigematsu A, Kondo N: "The mitochondrial acetoacetyl-CoA thiolase (T2) deficiency in Japanese patients : urinary organic acid and blood acylcarnitine profie
Fukao T、Zhang GX、Sakura N、Kubo T、Yamaga H、Hazama A、Kohno Y、Matsuo N、Kondo M、Yamaguchi S、Shigematsu A、Kondo N:“日本患者的线粒体乙酰乙酰辅酶A硫解酶 (T2) 缺乏症
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Shigematsu Y, Hirano S, Hata I, Tanaka Y, Sudo M, Sakura N, Tajima T, Yamaguchi S.: "Newborn mass screening and selective screening using electrospray tandem mass spectrometry in Japan."J Chromatogr B. 776. 39-48 (2002)
Shigematsu Y、Hirano S、Hata I、Tanaka Y、Sudo M、Sakura N、Tajima T、Yamaguchi S.:“日本使用电喷雾串联质谱法进行新生儿大规模筛查和选择性筛查。”J Chromatogr B. 776. 39-48
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SHIGEMATSU Yosuke其他文献

SHIGEMATSU Yosuke的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SHIGEMATSU Yosuke', 18)}}的其他基金

Development of useful methods to improve the accuracy in newborn screening by tandem mass spectrometry
开发有用的方法来提高串联质谱新生儿筛查的准确性
  • 批准号:
    20591218
  • 财政年份:
    2008
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Research for the newborn screening system by tandem mass spectrometry
串联质谱新生儿筛查系统的研究
  • 批准号:
    11670749
  • 财政年份:
    1999
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Profiling Analysis of Sugar Phosphates, Sugar Alcohols and Sugar Acids and Its Application to The Studies in Disorders of Sugar Metabolism.
糖磷酸盐、糖醇和糖酸的谱分析及其在糖代谢紊乱研究中的应用。
  • 批准号:
    02670430
  • 财政年份:
    1990
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似国自然基金

L-carnitine调控红细胞S1P释放治疗青光眼的机制探究
  • 批准号:
    2025JJ60575
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于“肠道菌群-Carnitine代谢—白色脂肪棕色化”途径研究苓桂术甘汤治疗肥胖症的作用机制
  • 批准号:
    82104716
  • 批准年份:
    2021
  • 资助金额:
    24.00 万元
  • 项目类别:
    青年科学基金项目
基于OCTN2调控机制的新型非典型抗精神病药物致脂代谢异常研究
  • 批准号:
    81773804
  • 批准年份:
    2017
  • 资助金额:
    59.5 万元
  • 项目类别:
    面上项目
L-carnitine(左旋肉碱)在视网膜色素上皮细胞-间充质细胞转换过程中的作用及机制研究
  • 批准号:
    81500727
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Cellular and Metabolic Dysfunction in Sepsis-Induced Immune Paralysis
脓毒症引起的免疫麻痹中的细胞和代谢功能障碍
  • 批准号:
    10724018
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Metabolic mechanisms underlying bronchopulmonary dysplasia-associated pulmonary hypertension
支气管肺发育不良相关肺动脉高压的代谢机制
  • 批准号:
    10736803
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Allosteric regulation of lysine degradation as a novel pathophysiological mechanism in glutaric aciduria type 1
赖氨酸降解的变构调节作为 1 型戊二酸尿症的一种新的病理生理机制
  • 批准号:
    10720740
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
  • 批准号:
    10649275
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Metabolic impact of Intralipid on synaptic function as a mechanism of resuscitation in local anesthetic systemic toxicity
脂肪乳对突触功能的代谢影响作为局麻药全身毒性复苏的机制
  • 批准号:
    10572885
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Adipose tissue mediates cardiac metabolic remodeling in the pathologically stressed heart in the absence of primary metabolic stress
在没有主要代谢应激的情况下,脂肪组织介导病理应激心脏的心脏代谢重塑
  • 批准号:
    10657015
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Alcohol-induced Gut Dysbiosis and Cardiovascular Disease
酒精引起的肠道菌群失调和心血管疾病
  • 批准号:
    10901520
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Adenylate Kinase 2 Deficiency and the Failure of Myelopoiesis
腺苷酸激酶 2 缺乏和骨髓生成失败
  • 批准号:
    10906528
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Endothelial Metabolic Reprogramming by Interferon-gamma in Coronary Artery Disease
干扰素γ在冠状动脉疾病中的内皮代谢重编程
  • 批准号:
    10662850
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Dysregulation of PPARα in RPE degeneration
RPE 变性中 PPARα 的失调
  • 批准号:
    10736062
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了